Product Information
DROSP-EE-LEVOMEF 3-0.02-0.451 is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $1.4023 per EA under NDC 68180089473. Its NADAC has been published 289 times since Feb 10, 2021.
FDA first approved this application on Jun 13, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DROSP-EE-LEVOMEF 3-0.02-0.451
drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calciumManufacturer
Lupin Pharmaceuticals Inc.NDC
68180089473
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA205947FDA Approved
6/13/2018
TE Code
AB
On Market Since
8/22/2018
Price Statistics
The NADAC for DROSP-EE-LEVOMEF 3-0.02-0.451 has been published 289 times since Feb 10, 2021, and over the history we have for it it has declined 62.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4023 per EA |
|---|---|
| All-time high | $4.5285 (Apr 13, 2022) |
| All-time low | $1.2304 (Jul 17, 2024) |
| 52-week high | $1.6322 |
| 52-week low | $1.2523 |
| Median price | $2.4069 |
| Average price | $2.3944 |
| Largest weekly change | -47.8% (Apr 17, 2024) |
| Weeks tracked | 289 |
| Tracking since | Feb 10, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the drospirenone, ethinyl estradiol and levomefolate calcium and levomefolate calcium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSP-EE-LEVOMEF 3-0.02-0.451?
The current National Average Drug Acquisition Cost (NADAC) for DROSP-EE-LEVOMEF 3-0.02-0.451, manufactured by Lupin Pharmaceuticals Inc., is $1.4023 per EA (NDC 68180089473), effective Aug 19, 2026.
How has the price of DROSP-EE-LEVOMEF 3-0.02-0.451 changed over time?
Over the history we have for it, the NADAC for DROSP-EE-LEVOMEF 3-0.02-0.451 has declined 62.2%. It has been tracked across 289 weekly CMS publications since Feb 10, 2021.
What are the highest and lowest recorded NADAC prices for DROSP-EE-LEVOMEF 3-0.02-0.451?
Since Feb 10, 2021, the NADAC for DROSP-EE-LEVOMEF 3-0.02-0.451 has ranged from a low of $1.2304 (Jul 17, 2024) to a high of $4.5285 (Apr 13, 2022), with a median of $2.4069 per EA.
Are there cheaper alternatives to DROSP-EE-LEVOMEF 3-0.02-0.451?
No other NADAC-published product currently shares the active ingredient and strength of DROSP-EE-LEVOMEF 3-0.02-0.451 in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DROSP-EE-LEVOMEF 3-0.02-0.451?
DROSP-EE-LEVOMEF 3-0.02-0.451 (NDC 68180089473) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.